Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.10B | $1.09B | $983.68M | $843.92M | $662.04M | $536.54M |
| Cost of Revenue | $801.72M | $745.46M | $663.88M | $578.51M | $467.86M | $398.52M |
| Gross Profit | $302.32M | $339.89M | $319.80M | $265.40M | $194.18M | $138.02M |
| Gross Margin | 27.38% | 31.32% | 32.51% | 31.45% | 29.33% | 25.72% |
| Operating Expenses | $141.18M | $139.17M | $127.37M | $103.18M | $91.07M | $75.80M |
| Operating Income | $161.14M | $200.72M | $192.43M | $162.22M | $103.11M | $62.22M |
| Operating Margin | 14.60% | 18.49% | 19.56% | 19.22% | 15.57% | 11.60% |
| Net Income | $117.78M | $145.63M | $142.85M | $134.32M | $78.51M | $39.20M |
| Net Margin | 10.67% | 13.42% | 14.52% | 15.92% | 11.86% | 7.31% |
| EPS (Basic) | $0.43 | $0.55 | $0.53 | $0.53 | $0.28 | $0.15 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A |